StonvexLoading…
StonvexStonvexStonvexCore line items from AHCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.24B | $3.26B | $3.20B | $2.97B |
Operating Income | $90.87M | $263.73M | $-598.40M | $190.41M |
Net Income | $-70.79M | $90.42M | $-678.89M | $69.32M |
EPS (Diluted) | $-0.52 | $0.61 | $-5.31 | $0.33 |
Total Assets | $4.32B | $4.49B | $4.51B | $5.22B |
Total Liabilities | $2.79B | $2.91B | $3.04B | $3.06B |
Cash & Equivalents | $106.14M | $109.75M | $77.13M | $46.27M |
Free Cash Flow OCF − CapEx | $219.38M | $235.78M | $143.20M | $-17.56M |
Shares Outstanding | 135.45M | 134.60M | 132.63M | 134.44M |